The North American Menopause Society’s (NAMS) updated position statement on nonhormonal management of menopause-associated vasomotor symptoms (VMS) offers recommendations and cautions to clinicians on the array of nonhormonal management options currently available to midlife women to help prevent underuse of effective therapies or use of inappropriate or ineffective therapies.
Among the recommendations are:
• Cognitive-behavioral therapy, and to a lesser degree, clinical hypnosis.
• Paroxetine salt is the only FDA-approval nonhormonal medication for the management of VMS.
Recommend with caution:
• Weight loss
• Mindfulness-based stress reduction
• S-equol derivative of soy isoflavones
• Stellate ganglion block
Do not recommend at this time:
• Cooling techniques
• Avoidance of triggers
• Exercise, yoga, paced respiration
• Over-the-counter supplements and herbal therapies
• Acupuncture, calibration of neural oscillations, chiropractic interventions
Citation: Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. [Published online ahead of print September 21, 2015]. doi: 10.1097/GME.0000000000000546.
This Week's Must Reads
Must Reads in Menopause
Menopause Symptom Burden and Chronic Pain, Menopause; ePub 2019 Mar 4; Gibson, et al
Trends in Menopausal Hormone Therapy, Menopause; ePub 2018 Dec 21; Crawford, et al
Chronic Disease Risk with Vaginal Estrogen Use, Menopause; ePub 2018 Dec 17; Bhupathiraju, et al
Sleep Disturbance After Surgical Menopause, Menopause; ePub 2018 Nov 12; Cho, Kim, et al
Cardiac Autonomic Function in Midlife Women, Menopause; ePub 2018 Jun 18; Fu, et al